Has Edward Walsh received payments from drug or device companies?

Yes. Drug and device makers reported $86,194 in general payments to Edward Walsh across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Walsh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Walsh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Walsh

Infectious Disease · Rochester, NYNPI 1407881097

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Modernatx, Inc. at 37.2% of the total. Reporting peaked in 2024 at $39,601 and has fallen 81.0% since, to $7,507 in 2025. Among infectious disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,194in general payments, 2019–2025

Across 80 payments — averaging $1077.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$32K
Pfizer$17K
Janssen Global Services, LLC$10K
Sanofi Pasteur Inc.$8K
Merck$8K
GSK$7K
plus $4K from 4 others

$3,839,998in research payments, 2019–2025

Across 235 payments — averaging $16,340 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$3.2M
Merck$610K
AstraZeneca$8K

What the payments were for

Consulting fees$27,43832%
Speaking & faculty fees$8,26010%
Travel & lodging$48,00556%
Food & beverage$2,3263%
Education$1450%
Gifts$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	24	$32,107
Pfizer	19	$16,823
Janssen Global Services, LLC	7	$9,985
Sanofi Pasteur Inc.	1	$8,260
Merck	3	$8,159
GSK	15	$6,944
Gilead	1	$3,150
AstraZeneca	7	$599
Astellas Pharma US Inc	2	$145
Melinta Therapeutics, LLC	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ABRYSVO$14,833

How this compares

$86,194 in reported general payments places this provider in the 95th percentile of 799 infectious disease providers in New York.

See all infectious disease providers in New York →

Other infectious disease in Rochester

Ann FalseyRochester$135K
Emil LeshoRochester$68K
Michael MancenidoRochester$32K
William ValentiRochester$22K
Harish MoorjaniBriarcliff Manor$733K
Sorana Segal MaurerFlushing$598K
Sian JonesNew York$406K
Antonio UrbinaNew York$373K
David BekhorNew York$358K
Andre BrutusBrooklyn$303K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →